Self Reported Oral Pain and Dysfunctions Associated with Radiation Induced Oral Mucositis among Head and Neck Cancer Patients-A Prospective Observational Study

Thomas, Prabha Lis; Kaur, Harmeet; Rishi, Karthik S

doi:10.5958/0976-5506.2019.00296.1

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Prevalence of oral mucositis, typically described by patients as presence of mouth or throat sores, was reported in 15 studies, ranging from 44% and 68% prior to treatment [73,74,[77][78][79][80][81]88,[107][108][109][110][111][112][113]. Elting et al reported that patients who received chemotherapy had higher prevalence than those without [108].…”

Section: Oral Mucositismentioning

confidence: 99%

See 1 more Smart Citation

Identifying Patient-Reported Outcome Measures (PROMs) for Routine Surveillance of Physical and Emotional Symptoms in Head and Neck Cancer Populations: A Systematic Review

Faria

Hurwitz

Kim

et al. 2021

JCM

View full text Add to dashboard Cite

The aims of this review were to identify symptoms experienced by head and neck cancer (HNC) patients and their prevalence, as well as to compare symptom coverage identified in HNC specific patient-reported outcome measures (PROMs). Searches of Ovid Medline, Embase, PsychInfo, and CINAHL were conducted to identify studies. The search revealed 4569 unique articles and identified 115 eligible studies. The prevalence of reported symptoms was highly variable among included studies. Variability in sample size, timing of the assessments, and the use of different measures was noted across studies. Content mapping of commonly used PROMs showed variability and poor capture of prevalent symptoms, even though validation studies confirmed satisfactory reliability and validity. This suggests limitations of some of the tools in providing an accurate and comprehensive picture of the patient’s symptoms and problems.

show abstract

Section: Oral Mucositismentioning

confidence: 99%

“…Arribas et al reported high prevalence immediately post-treatment (85%), with prevalence declining over time (45% one month after RT and 5% three months after RT) [73]. Thomas et al reported that subjects who had developed oral mucositis at the end of third week had all progressed to grade 3 or 4 mucositis by the end of therapy [113].…”

Section: Oral Mucositismentioning

confidence: 99%